Cite
HARVARD Citation
Weinblatt, M. et al. (2014). SAT0244 A Phase Iib Study of the Efficacy and Safety of Subcutaneous Clazakizumab (ANTI-IL-6 Monoclonal Antibody) with or without Methotrexate in Adults with Moderate-To-Severe Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate. Annals of the rheumatic diseases. pp. 680-681. [Online].